Neuraptive Therapeutics Announces Presentation of Phase 2 Topline Interim Results for NTX-001 at the 2024 American Society for Surgery of the Hand (ASSH) Annual Meeting

Chesterbrook, Pa., United States:   Neuraptive Therapeutics Inc., a leading biopharmaceutical company focused on novel treatments for peripheral nerve injuries, today

READ MORE

UNION therapeutics to present orismilast Phase 2b results in atopic dermatitis as a late-breaking oral presentation at the EADV Congress 2024

ADESOS Phase 2b results with orismilast in atopic dermatitis (AD) selected as late-breaking oral presentation Additionally, two posters on data

READ MORE

Experian Ranked 7th on 2024 IDC FinTech Rankings Top 100 Wins IDC Real Results Award in Bank Deposit Transformation

Costa Mesa, Calif., United States:   Experian has been ranked 7th on the 2024 IDC FinTech Rankings, placing in the top

READ MORE

Environmental Factor – January 2023: GenX Exposure Study reports results back to the community

Following the discovery of high levels of per- and polyfluoroalkyl substances (PFAS) in the blood of GenX Exposure Study participants, researchers are working quickly to

READ MORE

Environmental Factor – February 2024: Grantees create framework to report back environmental health results

NIEHS-funded researchers have created a new framework designed to help scientists report back study findings about potential exposures to participants. The 12-point framework, developed by

READ MORE

SLB achieves breakthrough results in sustainable lithium production

Houston, United States:   Nevada demonstration plant integrates direct lithium extraction (DLE), concentration and conversion technologies to sustainably produce lithium at

READ MORE